School Of Medicine Basic Sciences

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. Read More

Erin Calipari, assistant professor of pharmacology and of psychiatry and behavioral sciences, discusses the COVID-19 pandemic's impact on those struggling with opioid addiction. Read More

Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics.  Read More

Cornelius Taabazuing, a postdoctoral fellow at the Memorial Sloan-Kettering Cancer Center, will present “Investigating the molecular regulation and function of death signaling complexes.” The Discovery Science Emerging Scholars Lecture is scheduled for Thursday, Nov. 19, at 9:30 a.m. via Zoom. Read More

Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19. Read More

Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics and the Joe C. Davis Chair of Biomedical Science, receives one of the highest honors in health and medicine. Read More

Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics. Read More

Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read More

Histamine — commonly associated with allergies — also has a signaling role in the brain’s reward center and may offer a novel target for treating addiction. Read More

Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read More

Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people. Read More

New Assistant Professor of Pharmacology Rick Sando is interested in how neural circuits carry out specific functions when activated—and why these processes sometimes go awry. Read More

Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers. Read More

Craig Lindsley, the William K. Warren, Jr. Chair and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of Vanderbilt University’s Warren Center for Neuroscience Drug Discovery, effective Dec. 1, 2020. Read More

Three Vanderbilt University faculty members have been elected this year to the National Academy of Medicine, the organization announced Oct. 19. Read More

Three Vanderbilt faculty members—Nancy Carrasco, Velma McBride Murry and Consuelo Wilkins—have been elected this year to the National Academy of Medicine, the organization announced on Monday. Read More

A new method that keeps microbes and gut cells together will be useful for studies of complex host-microbe interactions and for analysis of clinical specimens. Read More

Melanie McReynolds, HHMI Hanna H. Gray Fellow at Princeton University, will present “NAD+ Flux is Maintained in Aged Mice” on Thursday, Oct. 29, at 9:30 a.m. via Zoom. This Discovery Sciences Emerging Scholars Lecture is co-sponsored by the Department of Molecular Physiology and Biophysics. Read More

Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read More

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read More